Clinical and Diagnostic Laboratory Immunology, November 2005, p. 1328-1330, Vol. 12, No. 11
1071-412X/05/$08.00+0 doi:10.1128/CDLI.12.11.1328-1330.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Serological Markers (Anti-Saccharomyces cerevisiae Mannan Antibodies and Antineutrophil Cytoplasmic Antibodies) in Inflammatory Bowel Disease: Diagnostic Utility and Phenotypic Correlation
M. S. Buckland,1*
M. Mylonaki,2
D. Rampton,2 and
H. J. Longhurst1
Department of Clinical Immunology, St. Bartholomew's, London, United Kingdom,1
Department of Adult and Paediatric Gastroenterology, Barts, and The London School of Medicine and Dentistry, London, United Kingdom2
Received 4 August 2005/
Returned for modification 6 September 2005/
Accepted 8 September 2005
We have evaluated the utility of antineutrophil cytoplasmic antibodies and anti-Saccharomyces cerevisiae mannan antibodies for distinguishing Crohn's disease from ulcerative colitis and other diarrheal illnesses by evaluating sera from 396 patients. Sensitivity, specificity, and phenotypic correlations were investigated. The implications of our findings for implementing these tests in routine clinical testing are discussed.
* Corresponding author. Mailing address: Department of Clinical Immunology, 1st Floor, 51-53 Barts Close, W. Smithfield, St. Bartholomew's, London EC1A 7BE, United Kingdom. Phone: 44 207 601 8229. Fax: 44 207 601 7031. E-mail: matthew.buckland{at}bartsandthelondon.nhs.uk.
Clinical and Diagnostic Laboratory Immunology, November 2005, p. 1328-1330, Vol. 12, No. 11
1071-412X/05/$08.00+0 doi:10.1128/CDLI.12.11.1328-1330.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Copyright © 2005 by the American Society for Microbiology. All rights reserved.